Cristina López Vicario

Cristina obtained her degree in Pharmacy in 2008 at the University of Barcelona, Spain. She completed her official Master’s degree in Research, Development and Control of Pharmaceutical Drugs in 2009 at the same university where she developed PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. She also worked as a pharmacist technician in Boehringer Ingelheim, Malgrat de Mar, Spain. From 2010 to 2015 she completed her PhD at Dr. Joan Clària's research group at the Department of Biochemistry and Molecular Genetics, Hospital Clínic of Barcelona, Spain. Her thesis project aimed to investigate the role of lipid mediators in the context of hepatic complications associated to obesity. She was awarded the PhD Prize from DSM Science and Technology Award 2014 (Stockholm, Sweden), the PhD prize for learning new technologies 2015 (Madrid, Spain), the Best Prize RIKEN Center for Integrative Medical Sciences 2016 (Yokohama, Japan) and the Young Investigator Award 2016 at the VI European Workshop on Lipid Mediators (Frankfurt, Germany). Her current research is focused on mass spectrometry-based quantification of eicosanoids in patients with acute-on-chronic liver failure and obesity co-morbidities in collaboration with the Wheelock group at the Karolisnka Institute.